Literature DB >> 7648004

Insulin resistance and lipoprotein metabolism.

M R Taskinen1.   

Abstract

Dyslipidaemia in insulin resistance comprises elevated plasma triglycerides, decreased HDL, a preponderance of small, dense LDL and increased postprandial lipaemia. In terms of cause and effect, small, dense LDL, alimentary hyperlipidaemia and changes in HDL are consequences of elevated triglycerides. These abnormalities can become frequent if triglycerides exceed a threshold value of approximately 1.5 mmol/l. Therefore, it is mandatory to maintain plasma triglycerides as low as possible in noninsulin-dependent diabetic and insulin-resistant individuals to prevent the potentially atherogenic and metabolic consequences of hypertriglyceridaemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648004     DOI: 10.1097/00041433-199506000-00007

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  13 in total

Review 1.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.

Authors:  S Lahdenperä; M Syvänne; J Kahri; M R Taskinen
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

3.  Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-08       Impact factor: 4.698

Review 4.  Statins in type 2 diabetes mellitus: target on lipids and vascular wall function.

Authors:  M A van de Ree; F V van Venrooij; A E Meinders; I J A M Jonkers; I Berk-Planken; M V Huisman
Journal:  Neth Heart J       Date:  2003-03       Impact factor: 2.380

5.  Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.

Authors:  M Cassader; R Gambino; G Musso; N Depetris; F Mecca; P Cavallo-Perin; G Pacini; M Rizzetto; G Pagano
Journal:  Lipids       Date:  2001-10       Impact factor: 1.880

6.  Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.

Authors:  Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; Suryaprakash Raichur; Ravi K Damarla; Cynthia Gershome; Juluri Suresh; Ramanujam Rajagopalan
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

Review 7.  What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.

Authors:  Sean Carroll; Mike Dudfield
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Effects of rosiglitazone with insulin combination therapy on oxidative stress and lipid profile in left ventricular muscles of diabetic rats.

Authors:  Servet Kavak; Lokman Ayaz; Mustafa Emre
Journal:  Exp Diabetes Res       Date:  2012-07-05

9.  Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.

Authors:  Timothy C Nichols; Elizabeth P Merricks; Dwight A Bellinger; Robin A Raymer; Jing Yu; Diana Lam; Gary G Koch; Walker H Busby; David R Clemmons
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  The effect of two iso-caloric meals containing equal amounts of fats with a different fat composition on the inflammatory and metabolic markers in apparently healthy volunteers.

Authors:  Olga Raz; Arie Steinvil; Shlomo Berliner; Tovit Rosenzweig; Dan Justo; Itzhak Shapira
Journal:  J Inflamm (Lond)       Date:  2013-01-31       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.